Quebec Drug-Discovery Consortium to Name First Five Winners in C$12M Funding Initiative

The awardees, whose identities will be disclosed in the coming weeks, will each receive C$500,000 to C$1 million per year for up to three years to develop tools to improve drug-discovery research at Canadian pharmas Pfizer, AstraZeneca, and Merck Frosst.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.